Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 25, 2026 | CMS / Medicare | Billing and Coding: Implantable Automatic Defibrillators | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Breast Cancer Index (BCI) Gene Expression Test | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: DecisionDx-UM (Uveal Melanoma) | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Oncotype DX Breast Cancer for DCIS (Genomic Health) | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: EndoPredict Breast Cancer Gene Expression Test | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: NRAS Genetic Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Botulinum Toxin Type A & Type B | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: MGMT Promoter Methylation Analysis | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Pharmacogenomics Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Blood Product Molecular Antigen Typing | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Breast Cancer Assay: Prosigna | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Immune Globulin Intravenous (IVIg) | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: B-type Natriuretic Peptide (BNP) Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Chemodenervation | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Brain Natriuretic Peptide (BNP) Level | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Botulinum Toxins | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Implantable Automatic Defibrillators | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Implantable Automatic Defibrillators | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Implantable Automatic Defibrillators | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: FDA Approved CLL Companion Diagnostic Test | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: FDA Approved CLL Companion Diagnostic Test | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML) | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: PIK3CA Gene Tests | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: BCR-ABL | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Germline testing for use of PARP inhibitors | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Coverage of Intravenous Immune Globulin for Treatment of Primary Immune Deficiency Diseases in the Home Medicare Benefit Policy Manual, Chapter 15, 50.6 | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: FDA-Approved KRAS Tests | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Oncotype DX Colon Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Oncotype DX Breast Cancer Assay | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: MammaPrint | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: FDA-Approved EGFR Tests | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: FDA-Approved BRAF Tests | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID Update | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Wound Care and Debridement - Provided by a Therapist, Physician, NPP, or as Incident-to Services | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Botulinum Toxins | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Nerve Blockade for Treatment of Chronic Pain and Neuropathy | Codes changed |
| May 25, 2026 | UnitedHealthcare | Wigs | New policy |
| May 25, 2026 | UnitedHealthcare | Succeeding Carrier for Inpatient Admissions | New policy |
| May 25, 2026 | UnitedHealthcare | Site of Service Differential | New policy |
| May 25, 2026 | UnitedHealthcare | Radiopharmaceuticals and Contrast Media | New policy |
| May 25, 2026 | UnitedHealthcare | Oxford's Outpatient Imaging Self-Referral Policy | New policy |